Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers - Product Thumbnail Image

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

  • Report
  • 155 Pages
From
Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Sarcopenia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Sarcopenia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 81 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016 - Product Thumbnail Image

TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016

  • Report
  • 388 Pages
From
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals  - Product Thumbnail Image

TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals

  • Report
  • 294 Pages
From
Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017-2030 - Product Thumbnail Image

Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017-2030

  • Report
  • 443 Pages
From
Antibody Discovery: Services and Platforms, 2017-2027 - Product Thumbnail Image

Antibody Discovery: Services and Platforms, 2017-2027

  • Report
  • 306 Pages
From
Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market) - Product Thumbnail Image

Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market)

  • Report
  • 98 Pages
From
T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals - Product Thumbnail Image

T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals

  • Report
  • 230 Pages
From
Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022 - Product Thumbnail Image

Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022

  • Report
  • 80 Pages
From
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends - Product Thumbnail Image

Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends

  • Report
  • 252 Pages
From
Antibody Humanization and Affinity Maturation: Services and Platforms, 2017-2030 - Product Thumbnail Image

Antibody Humanization and Affinity Maturation: Services and Platforms, 2017-2030

  • Report
  • 224 Pages
From
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Corticosteroids, Colchicine, Urate-Lowering Agents), By Disease Condition (Acute Gout, Chronic Gout), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Corticosteroids, Colchicine, Urate-Lowering Agents), By Disease Condition (Acute Gout, Chronic Gout), And Segment Forecasts, 2014 - 2025

  • Report
  • 100 Pages
From
Global Diabetic Macular Edema Treatment Market 2018-2022 - Product Thumbnail Image

Global Diabetic Macular Edema Treatment Market 2018-2022

  • Report
  • 109 Pages
From
Diabetic Macular Edema Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Diabetic Macular Edema Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 316 Pages
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • 59 Pages
From
Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028

  • Report
  • 455 Pages
From
Loading Indicator
adroll